Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
03/25/1998 | EP0830373A1 Cd6 ligand |
03/25/1998 | EP0830347A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
03/25/1998 | EP0830140A1 A pluripotent vaccine against enveloped viruses |
03/25/1998 | EP0830139A1 Modified myelin protein molecules |
03/25/1998 | EP0830130A1 Tnf-alpha converting enzyme |
03/25/1998 | EP0802791A4 3,3-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds |
03/25/1998 | EP0799186A4 1,4,4-(trisubstituted)cyclohex-1-ene dimers and related compounds |
03/25/1998 | EP0799185A4 1,3,3-(trisubstituted)cyclohexane dimers and related compounds |
03/25/1998 | EP0799184A4 4,4-(disubstituted)cyclohexan-1-ol dimers and related compounds |
03/25/1998 | EP0799182A4 3,3-(disubstituted)cyclohexan-1-ol dimers and related compounds |
03/25/1998 | EP0799181A4 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds |
03/25/1998 | EP0799036A4 4,4-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds |
03/25/1998 | EP0799031A4 1,4,4-(trisubstituted)cyclohexane dimers and related compounds |
03/25/1998 | CN1177351A Hydroxylamine derivatives useful for enhancing molecular chaperon prodn. and the prepn. thereof |
03/25/1998 | CN1177343A Cell adhesion inhibitors |
03/25/1998 | CN1177342A Novel cationic lipids and the use thereof |
03/25/1998 | CN1177303A Application of lysozyme dimer |
03/25/1998 | CN1177301A Germanium yeast human diet nutritional supplement |
03/25/1998 | CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine |
03/25/1998 | CN1176964A New benzimidazole derivatives with antihistaminic activity |
03/25/1998 | CN1176826A Cyclosporin-containing topical pharmaceutical compostion |
03/24/1998 | US5731441 Hydroxamic acid derivatives with tricyclic substitution |
03/24/1998 | US5731337 Conformationally rigid bicycle and adamantane derivatives useful as α2 |
03/24/1998 | US5731336 Method for treating multiple sclerosis |
03/24/1998 | US5731332 Leukotriene antagonists; antiinflammatory agents, antiallergens |
03/24/1998 | US5731322 Octahydro-1H-pyrrolo 3,2-g!and 2,3-g!isoquinoline derivatives |
03/24/1998 | US5731319 Antiallergens; antihistamines |
03/24/1998 | US5731290 Method of improving the immune response |
03/24/1998 | US5731286 Cyclic neurokinin A antagonists |
03/24/1998 | US5731008 Electrically hydrolyzed salines as microbicides |
03/24/1998 | US5730998 Administering substance p antagonist |
03/24/1998 | US5730979 LO-CD2a antibody and uses thereof for inhibiting T cell activation and proliferation |
03/24/1998 | CA2211008A1 Nucleic acid constructs containing hybrid promoters for use in gene therapy |
03/19/1998 | WO1998011212A1 Ptx sensitive g proteins, the production and use thereof |
03/19/1998 | WO1998011129A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
03/19/1998 | WO1998011128A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
03/19/1998 | WO1998011109A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes |
03/19/1998 | WO1998011102A1 New pharmaceutically active compounds |
03/19/1998 | WO1998011095A1 Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors |
03/19/1998 | WO1998010792A1 Immune direction therapy |
03/19/1998 | WO1998010787A2 Pharmaceutical compositions for the treatment of immune disorders |
03/19/1998 | WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
03/19/1998 | WO1998010780A1 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF |
03/19/1998 | WO1998010749A1 Protein-lipid vesicles and autogenous vaccine comprising the same |
03/19/1998 | WO1998010652A1 NOVEL trpS |
03/19/1998 | CA2265928A1 C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
03/19/1998 | CA2265885A1 Pharmaceutical compositions for the treatment of immune disorders |
03/19/1998 | CA2265467A1 Ptx sensitive g proteins, the production and use thereof |
03/19/1998 | CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
03/19/1998 | CA2264646A1 Protein-lipid vesicles and autogenous vaccine comprising the same |
03/19/1998 | CA2264563A1 Isolated peptides which complex with hla-cw*16 molecules, and uses thereof |
03/19/1998 | CA2264236A1 New pharmaceutically active compounds |
03/19/1998 | CA2262818A1 Modified amino acids, pharmaceuticals containing these compounds and methods for their production |
03/19/1998 | CA2237314A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes |
03/18/1998 | EP0829480A2 Tetrazolyl-substituted quinuclidines as substance P antagonists |
03/18/1998 | EP0828833A1 Chemokine n-terminal deletion mutations |
03/18/1998 | EP0828732A1 Peptidyl compounds and their therapeutic use |
03/18/1998 | EP0828728A1 Phenyl dihydrobenzofuranes |
03/18/1998 | EP0828726A1 Tricyclic inhibitors of matrix metalloproteinases |
03/18/1998 | EP0828511A1 Vaccine composition containing polyribosylribitol phosphate and method for making same |
03/18/1998 | EP0828503A1 Treatment for inhibiting the progression of autoimmune disease |
03/18/1998 | EP0828493A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds |
03/18/1998 | EP0739214B1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS |
03/18/1998 | CN1176599A Pharmaceutical composition for piperidinoalkanol compounds |
03/18/1998 | CN1176598A Method and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
03/18/1998 | CN1176391A Monoclonal antibodies against human interleukin-4 and hybridowas producing the same |
03/18/1998 | CN1176250A HIV protease inhibitors useful for treatment of AIDS |
03/18/1998 | CN1176139A Fowl Marek's disease vaccine sgnergist and its preparation |
03/18/1998 | CN1176101A N -(4 -aryl -thiazol -2 -yl) -sulphonamide derivatives and their use |
03/18/1998 | CN1037773C Heteroatoms-containing tricyclic compounds |
03/18/1998 | CN1037770C Method for preparing substituted thiazolyl and substituted pyridinyl derivatives |
03/17/1998 | US5728846 Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives |
03/17/1998 | US5728844 Immunotherapeutic agents |
03/17/1998 | US5728819 Secreted proteins and polynucleotides encoding them |
03/17/1998 | US5728721 N-(4-trifluoromethyl)-5-methylisoxazole-4-carboxanilide, n-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide |
03/17/1998 | US5728716 Trachykinin peptide for nervous system disorders and cardiovascular disorders |
03/17/1998 | US5728710 Rapamycin derivatives |
03/17/1998 | US5728708 Pharmacologically active pyridine derivatives and processes for the preparation thereof |
03/17/1998 | US5728702 Bronchodilator agents, antiallergens or antiplatelet druggs |
03/17/1998 | US5728685 Selectin receptors for inflammation modulators |
03/17/1998 | US5728677 Administering a specified polypeptide to a mammal |
03/17/1998 | US5728541 Screening therapeutic or chemotherapeutic agents for efficacy as to a specific patient |
03/17/1998 | US5728536 Jak kinases and regulation of Cytokine signal transduction |
03/17/1998 | US5728520 Immunoreactive polypeptide compositions |
03/17/1998 | US5728388 Contacting sample comprising tumor-sensitized cells with superantigens to produce stimulated cells, infusing into tumor bearing host |
03/17/1998 | US5728378 Antitumor and antivirus agents |
03/12/1998 | WO1998010076A2 Phospholipase d and dna sequences |
03/12/1998 | WO1998009992A2 HTm4, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS |
03/12/1998 | WO1998009985A2 Anti-inflammatory peptides and uses thereof |
03/12/1998 | WO1998009980A1 Bh3 interacting domain death agonist |
03/12/1998 | WO1998009975A1 1,3-dicarboxylic germanium complex and its therapeutic use |
03/12/1998 | WO1998009970A2 Alkylated rapamycin derivatives |
03/12/1998 | WO1998009969A1 Novel aryl-pyridazines |
03/12/1998 | WO1998009961A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
03/12/1998 | WO1998009946A1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
03/12/1998 | WO1998009940A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
03/12/1998 | WO1998009656A1 Method for tolerizing a mammalian patient to administration of gene therapy virus vectors |
03/12/1998 | WO1998009653A1 Association of no syntase inhibitors with trappers of oxygen reactive forms |
03/12/1998 | WO1998009647A2 Cyanidin compositions and therapeutic and diagnostic uses therefor |
03/12/1998 | WO1998009630A1 Compounds and methods |